Shareholder Sues Life Science Co. Over $118M Merger
An investor in gene sequencing company Complete Genomics Inc. filed a putative class action on Thursday in California challenging a proposed $118 million takeover by the U.S. subsidiary of rival BGI-Shenzhen,...To view the full article, register now.
Already a subscriber? Click here to view full article